CME Group (CME) fundamentals: P/E, valuation, undervalued?
CME Group · Financials · ref. ETF XLF · price $280.94
In short — CME Group trades at 23.8× earnings (P/E), 21.7× forward, with a net margin of 63.4 % and revenue growth of +1 %. Read: Average P/E (P/E 24 (near the ~20-25 average)).
Is CME Group stock cheap or undervalued? A good time to buy? Here are its fundamentals — P/E, PEG, margin and income statement — to judge its valuation.
📈 1-year price
$280.94+5.3% over range
Aug 28, 25low $218.58 · high $326.46Aug 27, 26
📏 Click 2 points (left → right) to measure the change · click again to clear.
SellBuy
Hold
46% recommend buying · 13 analysts
Valuation : Average P/E — P/E 24 (near the ~20-25 average)
Valuation
23.8
P/E (price/earnings)
21.7
Forward P/E
9.52
PEG
3.8
Price/book (P/B)
$101.0B
Market cap
11.80
EPS
Profitability & growth
63.4 %
Net margin
+1 %
Revenue growth
+3 %
Earnings growth
$3.9B
Total debt
CME Group income statement
| Fiscal year | Revenue | Net income | Margin |
|---|---|---|---|
| 2022 | $5.0B | $2.7B | 52.9 % |
| 2023 | $5.6B | $3.2B | 57.1 % |
| 2024 | $6.1B | $3.5B | 56.8 % |
| 2025 | $6.5B | $4.0B | 61.7 % |
⚠️ Indicative financial data (Yahoo Finance), not investment advice. Amounts in $.
Frequently asked questions
What is CME Group's P/E and is the stock undervalued? What's a good P/E?
CME Group's P/E is 23.8 (forward 21.7). Below ~15 = fairly cheap, above ~30 = expensive. Our valuation verdict: "Average P/E".
Is CME Group profitable?
CME Group has a net margin of 63.4 % (EPS 11.80). The company is profitable.
Is CME stock expensive?
Our read: "Average P/E" — P/E 24 (near the ~20-25 average). Cross-check with growth and sector.
💬 A question about CME Group? The JPI assistant answers using our backtest data.